News Industry News InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days September 16, 2014
News Conference News TCT 2014 Keynote Address Focuses on Newer DES, Problematic Subgroups September 15, 2014
News Conference News TCT 2014 SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES September 15, 2014
News Conference News TCT 2014 Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award September 15, 2014
News Industry News Neovasc Reducer™ Featured in Live Case Session at TCT 2014 Scientific Symposium September 15, 2014
News Conference News TCT 2014 VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size September 15, 2014
News Conference News TCT 2014 OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation September 15, 2014
News Conference News TCT 2014 SYMPLICITY HTN-3 Substudy Examines BP Response Factors in African Americans Yael L. Maxwell September 15, 2014